This metabolite provides a PDE selectivity profile just like sildenafil and an in vitro potency for PDE5 about fifty% with the mother or father drug. Plasma concentrations of the metabolite are about forty% of All those noticed for sildenafil, so the metabolite accounts for around 20% of sildenafil's pharmacologic consequences.At single oral doses